ATE428312T1 - Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung - Google Patents
Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdungInfo
- Publication number
- ATE428312T1 ATE428312T1 AT04001937T AT04001937T ATE428312T1 AT E428312 T1 ATE428312 T1 AT E428312T1 AT 04001937 T AT04001937 T AT 04001937T AT 04001937 T AT04001937 T AT 04001937T AT E428312 T1 ATE428312 T1 AT E428312T1
- Authority
- AT
- Austria
- Prior art keywords
- mental fatigue
- ginkgo
- memory
- relief
- improve
- Prior art date
Links
- 241000218628 Ginkgo Species 0.000 title abstract 3
- 235000011201 Ginkgo Nutrition 0.000 title abstract 3
- 235000008100 Ginkgo biloba Nutrition 0.000 title abstract 3
- 208000019914 Mental Fatigue Diseases 0.000 title abstract 3
- 230000003931 cognitive performance Effects 0.000 title 1
- 230000003920 cognitive function Effects 0.000 abstract 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04001937A EP1559430B1 (de) | 2004-01-29 | 2004-01-29 | Verwendung von Ginkgokomplexen zur Verbesserung von kognitiven Leistungen und Linderung der mentalen Ermüdung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE428312T1 true ATE428312T1 (de) | 2009-05-15 |
Family
ID=34639409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04001937T ATE428312T1 (de) | 2004-01-29 | 2004-01-29 | Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8591965B2 (de) |
| EP (1) | EP1559430B1 (de) |
| JP (1) | JP5300196B2 (de) |
| KR (2) | KR101249667B1 (de) |
| CN (1) | CN1913907B (de) |
| AT (1) | ATE428312T1 (de) |
| AU (1) | AU2005210091B2 (de) |
| CA (1) | CA2554760C (de) |
| DE (1) | DE602004020574D1 (de) |
| DK (1) | DK1559430T3 (de) |
| ES (1) | ES2323864T3 (de) |
| HK (1) | HK1098380A1 (de) |
| IL (1) | IL177118A (de) |
| NO (1) | NO331190B1 (de) |
| PL (1) | PL219337B1 (de) |
| PT (1) | PT1559430E (de) |
| RU (1) | RU2368385C2 (de) |
| SG (1) | SG172727A1 (de) |
| SI (1) | SI1559430T1 (de) |
| WO (1) | WO2005074956A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100723609B1 (ko) * | 2006-04-28 | 2007-06-04 | 주식회사 유유 | 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법 |
| HUE041715T2 (hu) * | 2007-12-21 | 2019-05-28 | Dr Willmar Schwabe Gmbh & Co Kg | Ginkgo biloba levél-kivonat alkalmazása |
| ITTO20080532A1 (it) * | 2008-07-10 | 2010-01-11 | Euro Pharma S R L | Integratore dietetico atto al potenziamento neuronale e sensoriale |
| IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN103156022B (zh) * | 2011-12-09 | 2014-12-17 | 四川科伦药物研究有限公司 | 一种银杏叶保健茶及其制备方法 |
| AU2015348010B2 (en) * | 2014-11-20 | 2020-02-27 | Frutarom Limited | Phospholipid preparations for the improvement of communication skills |
| EP3443965A4 (de) | 2016-04-15 | 2020-02-19 | Hirokawa, Yoshihiro | Mittel zur heilung der kognitiven funktion |
| CN105901649A (zh) * | 2016-05-03 | 2016-08-31 | 王胜 | 一种含银杏提取物的植物盐及其制备方法 |
| RU2680809C2 (ru) * | 2016-12-20 | 2019-02-27 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ получения наноразмерной фитосомальной системы |
| US20200226948A1 (en) * | 2019-01-14 | 2020-07-16 | Robert Warren | Time and Attention Evaluation System |
| EP4084787A1 (de) * | 2020-01-03 | 2022-11-09 | Biosearch S.A. | Zusammensetzung zur verwendung bei der behandlung von kognitiven störungen |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929959A1 (de) * | 1979-07-24 | 1981-02-19 | Hoechst Ag | Thermoplastische kunststoffmasse |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
| EP1242105B3 (de) * | 1999-12-17 | 2009-08-12 | Pharmaton S.A. | Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermoegen |
| US6733797B1 (en) * | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
| KR20020069539A (ko) * | 2001-02-26 | 2002-09-05 | 주식회사 두산 | 뇌세포 보호용 조성물 |
| CN1625406A (zh) * | 2001-08-09 | 2005-06-08 | 底古萨食品配料有限公司 | 用于预防和治疗温血动物的应激状态的含有溶血磷脂酰丝氨酸的制剂 |
| JP2003169632A (ja) * | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
| JP2003261456A (ja) * | 2002-03-08 | 2003-09-16 | Howaizu:Kk | 脳の老化予防剤 |
| US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
-
2004
- 2004-01-29 AT AT04001937T patent/ATE428312T1/de active
- 2004-01-29 SI SI200431142T patent/SI1559430T1/sl unknown
- 2004-01-29 DK DK04001937T patent/DK1559430T3/da active
- 2004-01-29 ES ES04001937T patent/ES2323864T3/es not_active Expired - Lifetime
- 2004-01-29 EP EP04001937A patent/EP1559430B1/de not_active Expired - Lifetime
- 2004-01-29 PT PT04001937T patent/PT1559430E/pt unknown
- 2004-01-29 DE DE602004020574T patent/DE602004020574D1/de not_active Expired - Lifetime
-
2005
- 2005-01-26 RU RU2006127272/15A patent/RU2368385C2/ru active
- 2005-01-26 SG SG2011046141A patent/SG172727A1/en unknown
- 2005-01-26 KR KR1020117024637A patent/KR101249667B1/ko active IP Right Grant
- 2005-01-26 KR KR1020067015129A patent/KR101249633B1/ko active IP Right Grant
- 2005-01-26 CA CA2554760A patent/CA2554760C/en active Active
- 2005-01-26 US US10/587,468 patent/US8591965B2/en active Active
- 2005-01-26 JP JP2006550086A patent/JP5300196B2/ja active Active
- 2005-01-26 CN CN2005800033273A patent/CN1913907B/zh active Active
- 2005-01-26 PL PL380826A patent/PL219337B1/pl unknown
- 2005-01-26 WO PCT/EP2005/000738 patent/WO2005074956A1/en active Application Filing
- 2005-01-26 AU AU2005210091A patent/AU2005210091B2/en active Active
-
2006
- 2006-07-27 IL IL177118A patent/IL177118A/en active IP Right Grant
- 2006-07-27 NO NO20063463A patent/NO331190B1/no unknown
-
2007
- 2007-05-10 HK HK07104973.6A patent/HK1098380A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1098380A1 (en) | 2007-07-20 |
| KR101249667B1 (ko) | 2013-04-02 |
| RU2006127272A (ru) | 2008-02-10 |
| CA2554760A1 (en) | 2005-08-18 |
| PT1559430E (pt) | 2009-06-16 |
| PL219337B1 (pl) | 2015-04-30 |
| AU2005210091B2 (en) | 2010-06-03 |
| IL177118A (en) | 2011-03-31 |
| US8591965B2 (en) | 2013-11-26 |
| SI1559430T1 (sl) | 2009-08-31 |
| CA2554760C (en) | 2018-10-09 |
| DE602004020574D1 (de) | 2009-05-28 |
| RU2368385C2 (ru) | 2009-09-27 |
| NO20063463L (no) | 2006-07-27 |
| PL380826A1 (pl) | 2007-03-19 |
| SG172727A1 (en) | 2011-07-28 |
| ES2323864T3 (es) | 2009-07-27 |
| AU2005210091A1 (en) | 2005-08-18 |
| JP5300196B2 (ja) | 2013-09-25 |
| DK1559430T3 (da) | 2009-07-20 |
| EP1559430A1 (de) | 2005-08-03 |
| EP1559430B1 (de) | 2009-04-15 |
| KR20060130148A (ko) | 2006-12-18 |
| KR20110123289A (ko) | 2011-11-14 |
| NO331190B1 (no) | 2011-10-31 |
| KR101249633B1 (ko) | 2013-04-02 |
| CN1913907A (zh) | 2007-02-14 |
| IL177118A0 (en) | 2008-03-20 |
| CN1913907B (zh) | 2011-03-30 |
| US20080226757A1 (en) | 2008-09-18 |
| JP2007519668A (ja) | 2007-07-19 |
| WO2005074956A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063463L (no) | Anvendelse av ginkgo-komplekser til forsterkning av kognitive funksjoner samt lettelse av mental tretthet | |
| BRPI0511063A (pt) | lentes de contato coloridas com padrões de anel lìmbico e de ìris combinados | |
| GB0421639D0 (en) | Methods and compositions relating to alzheimer's disease | |
| BRPI0416799A (pt) | sistema de orientação de sono e métodos relacionados | |
| DK1774972T3 (da) | Anvendelse af selengær ved behandlingen af Alzheimers sygdom | |
| DE60204966D1 (de) | Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis | |
| WO2003075850A3 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
| McAllister et al. | Oral sensorimotor functions in typically developing children 3 to 8 years old; assessed by the Nordic orofacial test, NOT-S | |
| ATE525114T1 (de) | Kosmetikprodukt enthaltend ein bestandteil aus salmonidae-eierstockmembrane | |
| DE60230961D1 (de) | Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung | |
| DE60009145D1 (de) | Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen | |
| ATE552251T1 (de) | Thiophen- und furanverbindungen | |
| ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
| DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| ATE325616T1 (de) | Zusammensetzungen zur behandlung von angstzuständen und damit verbundenen erkrankungen | |
| DE602004024992D1 (de) | Verwendung von pyrazolopyridinen zur behandlung von kognitiven defiziten | |
| DE60213237D1 (de) | Verwendung von l-acetylcarnitin in kombination mit biotin zur behandlung von patienten mit insulinresistentem diabetes mellitus typ ii | |
| Sims | Coyte, Mary Ellen, Peter Gilbert and Vicky Nicholls (eds.). 2007. Spirituality, Values and Mental Health: Jewels for the Journey | |
| Berg | Psychiatric nurses' view of nursing care, clinical supervision and individualised care: Interventions on a dementia and on a general psychiatric ward. | |
| Rishel | Child outcomes in community mental health: Effects of maternal mental health status | |
| Ages | Compulsory school attendance | |
| Boularbah et al. | Richner-Hanhart syndrome | |
| Nassif | Investigating creativity with the MMPI-2: A preliminary creativity scale | |
| White et al. | Classifying mental and neurological conditions together: authors’ reply to letters | |
| Kawanobe | Affective mapping between music and color combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1559430 Country of ref document: EP |